News from scinopharm taiwan, ltd

Jul 11, 2014, 06:45 ET

ScinoPharm President & CEO Dr. Jo Shen to Retire, Dr. Yung-Fa (Fred) Chen to Succeed

ScinoPharm (TWSE:1789) announced that after 17 years of dedicated service, its co-founder and President & CEO Dr. Jo Shen is retiring at the...

Jun 08, 2014, 20:40 ET

ScinoPharm to Provide Active Pharmaceutical Ingredient to F*TaiGen for Novel Stem Cell Drug

ScinoPharm Taiwan, Ltd. (TWSE: 1789) specializing in the development and manufacture of active pharmaceutical ingredients, and TaiGen Biotechnology...

May 09, 2014, 02:30 ET

ScinoPharm and Lee's Pharmaceutical Jointly Develop a Number of Drug Products for the Chinese Market

ScinoPharm Taiwan, Ltd. (TWSE:1789), a specialty Active Pharmaceutical ingredient (API) company, and Lee's Pharmaceutical Holdings Limited (950.HK)...

Feb 14, 2014, 01:00 ET

ScinoPharm Reports Financial Performance for 2013

ScinoPharm (TWSE:1789) an active pharmaceutical ingredient (API) specialty company, announced unaudited record results for its fiscal year 2013....

Dec 12, 2013, 01:00 ET

ScinoPharm Completes Changshu, China Plant

 ScinoPharm (TWSE:1789) today announced that the company has completed construction of its Changshu plant on a 16-acre (6.5-hectare) site. The...

Nov 11, 2013, 00:30 ET

Genovate and ScinoPharm Co-Develop Hepatitis B Drug "Livepro" -- To be Commercially Available by the End of the Year in Taiwan

Genovate Biotechnology Co. Ltd. (4130:TT) and ScinoPharm Taiwan Ltd. (1789:TT) announced today that they have jointly developed the highly potent...

Sep 09, 2013, 02:55 ET

ScinoPharm to Provide Active Pharmaceutical Ingredient for Newly Launched Antiepileptic Drug Trokendi XR(TM) in the US

ScinoPharm Taiwan Ltd. (TSE: 1789.TW) announced that its Tainan, Taiwan Facility provides commercial manufacturing of topiramate active...

Aug 07, 2013, 02:30 ET

ScinoPharm Changshu and Sundia MediTech Establish Strategic Alliance for Pharmaceutical Contract Research and Manufacturing in China

ScinoPharm (Changshu) Pharmaceuticals and Sundia MediTech Company Ltd. announced today a strategic alliance to seek more opportunities...

May 10, 2013, 02:00 ET

ScinoPharm Taiwan and Coland Holdings Establish Strategic Alliance for Oncological Injectable Products for China

 ScinoPharm Taiwan Ltd. (TSE: 1789.TW) and Coland Holdings Ltd. (TSE: 4144.TW) announced today that they have formed a strategic alliance to...

Jan 30, 2013, 02:19 ET

ScinoPharm and Foresee Pharmaceuticals Entered into an Agreement to Establish a Joint Venture for Developing Novel Oncological Peptide Drugs

 ScinoPharm (TWSE: 1789) and Foresee Pharmaceuticals, Inc. (Foresee) jointly announced today that an investment agreement to form a joint...

Jul 18, 2012, 23:28 ET

ScinoPharm to Provide Contract Manufacturing Services for VIVUS' Newly-Approved Anti-Obesity Drug, Qsymia(TM)

ScinoPharm (TWSE:1789) announced today that its Tainan, Taiwan Facility will provide commercial manufacturing of topiramate active...

Jun 29, 2012, 05:00 ET

ScinoPharm Invests NT$1.13 Billion in High Potency Cytotoxic Injectable Plant Facility -- Extending Services into Oncological Injectable Product Production

ScinoPharm (TWSE:1789) announced today that it will invest NT$1.13 billion (approximately US$37.6 million) in the construction of a high potency...

Feb 08, 2011, 23:50 ET

ScinoPharm übernimmt Auftragsfertigung für neu entwickeltes Antidepressivum in den Vereinigten Staaten

ScinoPharm, ein führendes Unternehmen für aktive pharmazeutische Wirkstoffe (API), das ausserdem im Bereich der Auftragsforschung...

Feb 08, 2011, 23:48 ET

ScinoPharm agira en tant que prestataire de service de fabrication en sous-traitance pour des médicaments antidépresseurs récemment approuvés aux États-Unis

ScinoPharm, un prestataire de premier plan de service de recherche et de fabrication sous contrat (CRAM) d'ingrédients pharmaceutiques...

Feb 08, 2011, 23:45 ET

ScinoPharm proporciona servicio de fabricación por contrato para el Nuevo fármaco contra la depresión

- ScinoPharm proporciona servicio de fabricación por contrato para el nuevo fármaco aprobado contra la depresión en Estados...

Feb 08, 2011, 02:00 ET

ScinoPharm to Provide Contract Manufacturing Service for Newly Approved Antidepressant Drug in the United States

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global...

Aug 31, 2010, 08:00 ET

ScinoPharm to Invest in Tanvex Biologics

ScinoPharm, a leading active pharmaceutical ingredient (API) developer and manufacturer headquartered in Taiwan, today announced an investment into...

Mar 25, 2010, 01:00 ET

ScinoPharm Reports Final FY2009 Results

ScinoPharm, an active pharmaceutical ingredient (API) specialist, today announced audited record results for its fiscal year 2009. The company...

Nov 19, 2009, 16:00 ET

ScinoPharm Announces SafeBridge Potent Compound Safety Certification

ScinoPharm, a leading global supplier of active pharmaceutical ingredients (APIs), announced that its Tainan facility has received the Potent...

Nov 05, 2009, 07:40 ET

ScinoPharm Breaks Ground for Changshu Plant

ScinoPharm, a leading global supplier of active pharmaceutical ingredients (APIs), has commenced construction of a new plant on a 66670 square...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer